From laboratory to clinical practice: Dabigatran effects on thrombin generation and coagulation in patient samples
- 1 July 2015
- journal article
- research article
- Published by Elsevier in Thrombosis Research
- Vol. 136 (1) , 154-160
Abstract
No abstract availableKeywords
Funding Information
- Helsingin ja Uudenmaan Sairaanhoitopiiri
This publication has 35 references indexed in Scilit:
- Comparison of calibrated dilute thrombin time and aPTT tests with LC-MS/MS for the therapeutic monitoring of patients treated with dabigatran etexilateThrombosis and Haemostasis, 2013
- Follow-Up of Thrombin Generation after Prostate Cancer Surgery: Global Test for Increased HypercoagulabilityPLOS ONE, 2012
- Active Online Assessment of Patients Using New Oral Anticoagulants: Bleeding Risk, Compliance, and Coagulation AnalysisSeminars in Thrombosis and Hemostasis, 2012
- Impact of dabigatran on a large panel of routine or specific coagulation assaysThrombosis and Haemostasis, 2012
- A combined pharmacometric analysis of dabigatran etexilate in healthy volunteers and patients with atrial fibrillation or undergoing orthopaedic surgeryThrombosis and Haemostasis, 2012
- The paradoxical stimulation by a reversible thrombin inhibitor of thrombin generation in plasma measured with thrombinography is caused by α2‐macroglobulin‐thrombinJournal of Thrombosis and Haemostasis, 2010
- Dabigatran enhances clot susceptibility to fibrinolysis by mechanisms dependent on and independent of thrombin‐activatable fibrinolysis inhibitorJournal of Thrombosis and Haemostasis, 2010
- Thrombin generation in patients after acute deep-vein thrombosisThrombosis and Haemostasis, 2008
- Three different patterns of calibrated automated thrombogram obtained with six different anticoagulantsJournal of Thrombosis and Haemostasis, 2007
- The Ecarin Clotting Time, a Universal Method to Quantify Direct Thrombin InhibitorsPathophysiology of Haemostasis and Thrombosis, 2003